Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 128 results for "harvard bone marrow initiative"

Harvard's bone marrow-on-a-chip could replace animal drug testing

Scientists at Harvard's Wyss Institute for Biologically Inspired Engineering have unveiled their newest tool for drug testing, dubbed bone marrow-on-a-chip, the first device of its kind that mimics the structure, functions and cellular make-up of ... BioScreening, 2 weeks ago

12 images for harvard bone marrow initiative

Business Journal of Jacksonville, 2 weeks ago
Jutia Group, 2 months ago
Market Pulse Navigator, 3 months ago
Scicasts, 4 months ago
Laboratory Equipment, 4 months ago
ALN, 4 months ago
Medical Design Online, 4 months ago
Medical Design Technology, 4 months ago
One News Page United Kingdom, 4 months ago
Harvard Medical School, 4 months ago
Product Design and Development

Engineering new bone growth

By a News Reporter-Staff News Editor at Biotech Week -- CAMBRIDGE, MA - MIT chemical engineers have devised a new implantable tissue scaffold coated with bone growth factors that are released slowly over a few weeks. When applied to bone injuries or ...
 HispanicBusiness.com1 month ago MIT - Engineering new bone growth  HispanicBusiness.com1 month ago Chemical engineers devise new implantable tissue scaffold coated with bone growth factors  News-Medical.Net1 month ago Engineering bone growth: Coated tissue scaffolds help body grow new bone to repair injuries or congenital defects  Science Daily1 month ago

Spread of multiple myeloma halted in mice

I n an advance against cancer metastasis, scientists at the Harvard-affiliated Dana-Farber Cancer Institute have shown that a specially developed compound can impede multiple myeloma in mice from spreading to the bones. The findings, published in ...
 Harvard University Gazette6 days ago Novel compound prevents metastasis of multiple myeloma in mouse studies  EurekAlert!6 days ago

HARVARD APPARATUS REGENERATIVE TECH : Is Regenerative Medicine a New Growth Market for Biotech Investors?

Medical technology is intimately linked to regenerative medicine. You could say these industries have a thunder-and-lightning relationship--you can't have one without the other. Mark Landy , director of research for medical technology and ...
 4 Traders1 month ago Is Regenerative Medicine a New Growth Market for Biotech Investors?  HispanicBusiness.com1 month ago Biotech Stock Directory Update  InvestorIdeas.com1 month ago New Growth Ideas for Biotech Stock Investors  Market Oracle1 month ago

ONLINE FIRST: Upfront Transplant in Multiple Myeloma? Clinicians' Choice Split

BY ROBERT H. CARLSON NEW YORK -- After a data-filled debate between two hematology experts on whether newly diagnosed multiple myeloma patients should be treated with transplantation right away or later on, the audience voted. And the ...
 Oncology Times4 days ago

Is a New Transdermal Anti-Depressant the Best in the World?

Dr. James Schaller of Naples Florida shares a scientific breakthrough which could change the lives of millions who suffer from depression and arthritis. Current synthetic antidepressants share problems that include weight gain, sexual dysfunction, ...
 PRWeb1 week ago

Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1.....predicting degree of reservoir reduction needed for cure

Download the PDF here September 16, 2014 PNAS Proceedings of the National Academy of Sciences of the United States of America Alison L. Hilla,b,1,2, Daniel I. S. Rosenblooma,c,1, Feng Fud, Martin A. Nowaka, and Robert F. Silicianoe,f ...
 National AIDS Treatment Advocacy Project1 week ago
Fred Hutchinson Cancer Research Center

Fred Hutchinson Cancer Research Center designated MIDAS Center of Excellence

SEATTLE Sept. 17, 2014 Researchers at Fred Hutchinson Cancer Research Center received a five-year, $12.5 million award from the National Institute of General Medical Sciences that designates the Seattle campus as a MIDAS Center of Excellence.
 Fred Hutchinson Cancer Research Center2 weeks ago

Novel Therapies with Potential to Be the Next Biotech Blockbuster

When Steve Brozak performs diligence on biotech stocks, he's always looking for an angle. Brozak, president and managing director at WBB Securities, wants to see how new technology platforms and novel ideas fit into tomorrow's healthcare system, ...
 Equities.com2 weeks ago Whats behind FDA's fast paced molecular entity approvals?  CommodityOnline3 weeks ago Steve Brozak: Big-Picture Biotech Stocks Rule the Future  Jutia Group3 weeks ago

Cellectis : R&D/ Analyst Day (Event report)

Genome Engineering & CART Cells: At the forefront of immuno-oncology Regulatory News: Cellectis (Paris:ALCLS) (Alternext: ALCLS.PA), a leader in the development of adoptive immunotherapies based on engineered allogeneic ...
 4 Traders2 weeks ago Event report: Cellectis R&D/ Analyst Day  Street Sweeper2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less